Psychemedics (PMD) Short Interest Ratio & Short Volume → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free PMD Stock Alerts $2.55 +0.01 (+0.39%) (As of 09:33 AM ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Psychemedics Short Interest DataCurrent Short Volume16,900 sharesPrevious Short Volume15,900 sharesChange Vs. Previous Month+6.29%Dollar Volume Sold Short$44,783.31Short Interest Ratio / Days to Cover1.9Last Record DateApril 15, 2024Outstanding Shares5,810,000 sharesFloat Size4,460,000 sharesShort Percent of Float0.38%Today's Trading Volume543 sharesAverage Trading Volume11,077 sharesToday's Volume Vs. Average5% Short Selling Psychemedics ? Sign up to receive the latest short interest report for Psychemedics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPMD Short Interest Over TimePMD Days to Cover Over TimePMD Percentage of Float Shorted Over Time Ad DTIHow a $0.25 cent option contract makes my top traders feelIf you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…Click now to see for yourself what $0.25 Cent Trades is all about Psychemedics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202416,900 shares $44,783.31 +6.3%0.4%1.9 $2.65 3/31/202415,900 shares $46,587.00 +7.4%0.4%1.3 $2.93 3/15/202414,800 shares $43,808.00 +27.6%0.4%1.1 $2.96 2/29/202411,600 shares $36,656.00 -0.9%0.3%0.9 $3.16 2/15/202411,700 shares $36,504.00 -10.7%0.3%0.9 $3.12 1/31/202413,100 shares $41,920.00 -29.6%0.3%0.9 $3.20 Get the Latest News and Ratings for PMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Psychemedics and its competitors with MarketBeat's FREE daily newsletter. 1/15/202418,600 shares $63,984.00 +87.9%0.4%1.3 $3.44 12/31/20239,900 shares $29,304.00 -36.5%0.2%0.6 $2.96 12/15/202315,600 shares $46,488.00 +31.1%0.3%1 $2.98 11/30/202311,900 shares $30,464.00 +1.7%0.3%0.8 $2.56 11/15/202311,700 shares $25,155.00 -34.3%0.3%0.8 $2.15 10/31/202317,800 shares $43,610.00 -25.8%0.4%1 $2.45 10/15/202324,000 shares $64,080.00 +25.7%0.5%1.3 $2.67 9/30/202319,100 shares $75,827.00 -32.3%0.4%1 $3.97 9/15/202328,200 shares $109,698.00 +1.4%0.6%1.7 $3.89 8/31/202327,800 shares $118,428.00 +102.9%0.6%1.7 $4.26 8/15/202313,700 shares $63,979.00 +15.1%0.3%0.8 $4.67 7/31/202311,900 shares $59,024.00 +41.7%0.3%0.9 $4.96 7/15/20238,400 shares $41,244.00 -27.6%0.2%0.7 $4.91 6/30/202311,600 shares $52,896.00 +2.7%0.3%1.2 $4.56 6/15/202311,300 shares $52,545.00 -8.1%0.3%1.2 $4.65 5/31/202312,300 shares $58,302.00 +5.1%0.3%1.4 $4.74 5/15/202311,700 shares $56,979.00 +24.5%0.3%1.7 $4.87 4/30/20239,400 shares $51,136.00 -19.7%0.2%1.5 $5.44 4/15/202311,700 shares $61,659.00 -4.1%0.3%2.1 $5.27 3/31/202312,200 shares $64,050.00 -19.2%0.3%2.3 $5.25 3/15/202315,100 shares $89,241.00 +17.1%0.4%2.7 $5.91 2/28/202312,900 shares $72,627.00 +2.4%0.3%2.3 $5.63 2/15/202312,600 shares $69,426.00 +15.6%0.3%2.3 $5.51 1/31/202310,900 shares $61,040.00 -2.7%0.3%1.8 $5.60 1/15/202311,200 shares $58,240.00 -1.8%0.3%1.8 $5.20 12/30/202211,400 shares $55,913.58 +2.7%0.3%1.8 $4.90 12/15/202211,100 shares $54,501.00 -9.0%0.3%1.6 $4.91 11/30/202212,200 shares $69,540.00 +47.0%0.3%2 $5.70 11/15/20228,300 shares $51,128.00 -3.5%0.2%1.3 $6.16 10/31/20228,600 shares $55,642.00 -6.5%0.2%1.5 $6.47 10/15/20229,200 shares $57,684.00 -7.1%0.2%1.6 $6.27 9/30/20229,900 shares $63,855.00 -25.6%0.2%1.7 $6.45 9/15/202213,300 shares $87,780.00 +41.5%0.3%2 $6.60 8/31/20229,400 shares $62,228.00 -31.4%0.2%1.5 $6.62The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him PMD Short Interest - Frequently Asked Questions What is Psychemedics' current short interest? Short interest is the volume of Psychemedics shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 16,900 shares of PMD short. 0.38% of Psychemedics' shares are currently sold short. Learn More on Psychemedics' current short interest. What is a good short interest ratio for Psychemedics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PMD shares currently have a short interest ratio of 2.0. Learn More on Psychemedics's short interest ratio. What is a good short interest percentage for Psychemedics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.38% of Psychemedics' floating shares are currently sold short. Is Psychemedics' short interest increasing or decreasing? Psychemedics saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 16,900 shares, an increase of 6.3% from the previous total of 15,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Psychemedics' float size? Psychemedics currently has issued a total of 5,810,000 shares. Some of Psychemedics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Psychemedics currently has a public float of 4,460,000 shares. How does Psychemedics' short interest compare to its competitors? 0.38% of Psychemedics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Psychemedics: Centogene (0.05%), BioNexus Gene Lab Corp. (1.41%), DermTech, Inc. (10.05%), OpGen, Inc. (1.36%), Exagen Inc. (0.15%), Enzo Biochem, Inc. (2.05%), T2 Biosystems, Inc. (6.80%), Aytu BioPharma, Inc. (7.51%), ETAO International Co., Ltd. (2.33%), Kiora Pharmaceuticals, Inc. (0.31%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Psychemedics stock? Short selling PMD is an investing strategy that aims to generate trading profit from Psychemedics as its price is falling. PMD shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Psychemedics? A short squeeze for Psychemedics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PMD, which in turn drives the price of the stock up even further. How often is Psychemedics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PMD, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Centogene Short Squeeze BioNexus Gene Lab Short Squeeze DermTech Short Squeeze OpGen Short Squeeze Exagen Short Squeeze Enzo Biochem Short Squeeze T2 Biosystems Short Squeeze Aytu BioPharma Short Squeeze ETAO International Short Squeeze Kiora Pharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PMD) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressThe only accurate crypto trading system I know …Weiss RatingsThe AI stock to buy right nowStockEarnings